MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Leukemia, Hematologic, Blood
Innate Pharma SA (NASDAQ: IPHA)*
Organization & Developments: Innate Pharma
Parents
Innate Pharma SA (NASDAQ: IPHA)*
Children
*Commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.
2021: Innate Pharma: Leading The NK Cell Immunotherapy Space
2022: Innate Pharma S.A. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2024: Innate Pharma: Looking Like A Company We'll Regret Ignoring
2024: Innate Pharma: Worth A Deeper Look_ seekingalpha.com
2025: Innate Pharma Announces Transformative Strategy to Accelerate Growth
2025: Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
2025: Innate Pharma: Moving Into The Padcev Space
2025: Innate: Lacutamab Treatment Program Moves Forward With Potential Expansion
Jumps
Finance & Acquisitions: Innate Pharma
Key People: Innate Pharma